Interest cover of 1.22 seems a bit tight.Also, the statement that they need another 12 months for any recapitalisation.Sounds like bottom drawer stuff for now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025